Church & Dwight
CHD · NYSESoap, Detergents, Cleang Preparations, Perfumes, Cosmetics · Fiscal year ends Dec 31
Church & Dwight reported revenue of $6.2B in the fiscal year ended Dec 2025, up 1.6% from the year before. Operating income was $1.1B, an operating margin of 17.4%, and net income was $737M. Operating cash flow of $1.2B less capital expenditure of $122M left free cash flow of $1.1B. Net debt was $1.8B.
Last 5 fiscal years
Revenue and net income
Income statement
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | $5.2B | $5.4B | $5.9B | $6.1B | $6.2B |
| Cost of revenue | $2.9B | $3.1B | $3.3B | $3.3B | $3.4B |
| Gross profit | $2.3B | $2.3B | $2.6B | $2.8B | $2.8B |
| Research & development | $105M | $110M | $122M | $140M | $146M |
| Selling, general & admin | $607M | $706M | $890M | $928M | $988M |
| Operating income | $1.1B | $598M | $1.1B | $807M | $1.1B |
| Interest expense | $55M | $90M | $111M | $95M | $95M |
| Pre-tax income | $1B | $523M | $967M | $756M | $957M |
| Income tax | $204M | $109M | $212M | $171M | $220M |
| Net income | $828M | $414M | $756M | $585M | $737M |
| Diluted EPS | 3.32 | 1.68 | 3.05 | 2.37 | 3.02 |
| Diluted shares | 250M | 246M | 248M | 247M | 244M |
Balance sheet
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Cash & equivalents | $241M | $270M | $345M | $964M | $409M |
| Receivables | $406M | $422M | $527M | $601M | $593M |
| Inventory | $535M | $647M | $613M | $613M | $535M |
| Current assets | $1.2B | $1.4B | $1.5B | $2.2B | $1.6B |
| Net PP&E | $653M | $761M | $928M | $932M | $823M |
| Goodwill | $2.3B | $2.4B | $2.4B | $2.4B | $2.6B |
| Total assets | $8B | $8.3B | $8.6B | $8.9B | $8.9B |
| Payables | – | $667M | $631M | $705M | $732M |
| Current liabilities | $2.1B | $1.2B | $1.4B | $1.3B | $1.5B |
| Short-term debt | $699M | $0 | $200M | $0 | $0 |
| Long-term debt | $2.2B | $2.6B | $2.2B | $2.2B | $2.2B |
| Total liabilities | $4.8B | $4.9B | $4.7B | $4.5B | $4.9B |
| Shareholders' equity | $3.2B | $3.5B | $3.9B | $4.4B | $4B |
Cash flow
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating cash flow | $994M | $885M | $1B | $1.2B | $1.2B |
| Capital expenditure | $119M | $179M | $224M | $180M | $122M |
| Free cash flow | $875M | $706M | $807M | $976M | $1.1B |
| Depreciation & amortisation | $219M | $219M | $225M | $239M | $247M |
| Stock-based compensation | $24M | $32M | $64M | $59M | $58M |
| Acquisitions | $556M | $547M | $0 | $20M | $656M |
| Share buybacks | $500M | $0 | $300M | $0 | $900M |
| Dividends paid | $248M | $255M | $267M | $277M | $287M |
| Dividend per share | 1.01 | 1.05 | 1.09 | 1.13 | 1.18 |
Key ratios
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue growth (YoY) | – | 3.6% | 9.2% | 4.1% | 1.6% |
| Operating income growth (YoY) | – | −44.6% | 76.9% | −23.7% | 33.5% |
| EPS growth (YoY) | – | −49.4% | 81.5% | −22.3% | 27.4% |
| Gross margin | 43.6% | 41.9% | 44.1% | 45.7% | 44.7% |
| Operating margin | 20.8% | 11.1% | 18.0% | 13.2% | 17.4% |
| Net margin | 15.9% | 7.7% | 12.9% | 9.6% | 11.9% |
| Return on equityBlank when equity is negative | 25.6% | 11.9% | 19.6% | 13.4% | 18.4% |
| ROCEEBIT ÷ (assets − current liabilities) | 18.2% | 8.3% | 14.8% | 10.7% | 14.5% |
| Free cash flow margin | 16.9% | 13.1% | 13.8% | 16.0% | 17.6% |
| Cash conversion (CFO ÷ net income) | 1.20x | 2.14x | 1.36x | 1.98x | 1.65x |
| Receivable days | 29 | 29 | 33 | 36 | 35 |
| Inventory days | 67 | 76 | 68 | 67 | 57 |
| Payable days | – | 78 | 70 | 78 | 78 |
| Interest cover | 19.8x | 6.67x | 9.53x | 8.50x | 11.3x |
| Debt ÷ equity | 0.90x | 0.74x | 0.62x | 0.51x | 0.55x |
| Net debtDebt − cash & equivalents; excludes investments; negative = net cash | $2.7B | $2.3B | $2.1B | $1.2B | $1.8B |
| Current ratio | 0.59x | 1.18x | 1.08x | 1.70x | 1.07x |
Recent filings
More in Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics
Standardised figures from the company's XBRL filings with the SEC (10-K, 10-Q). Line items follow US GAAP tags, so a company's own statement layout may differ and some lines show “–” where the company does not report that item. Ratios are calculated from these figures. For education only; not investment advice or a recommendation.